Detalles de la búsqueda
1.
Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis.
BMC Cancer
; 18(1): 148, 2018 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409466
2.
High Expression of Cathepsin E is Associated with the Severity of Airflow Limitation in Patients with COPD.
COPD
; 13(2): 160-6, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26488201
3.
[Effect of Wnt signaling suppression on gefitinib in non small cell lung cancer cell lines].
Zhonghua Bing Li Xue Za Zhi
; 42(7): 455-9, 2013 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-24246864
4.
[Evaluation of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of hilar and mediastinal tumors].
Zhonghua Jie He He Hu Xi Za Zhi
; 36(1): 22-6, 2013 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-23537538
5.
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia.
J Thorac Oncol
; 18(4): 436-446, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379356
6.
[The ultrastructural features of sputum deposition and its value in the diagnosis of pulmonary alveolar proteinosis].
Zhonghua Jie He He Hu Xi Za Zhi
; 35(12): 887-91, 2012 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-23328177
7.
Individualized Chemotherapy in Advanced NSCLC Patients Based on mRNA Levels of BRCA1 and RRM1.
Chin J Cancer Res
; 24(3): 226-31, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23359225
8.
A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study.
Front Oncol
; 11: 745699, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34804932
9.
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.
J Clin Oncol
; 39(7): 713-722, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33332190
10.
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes.
Nat Commun
; 12(1): 6450, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750392
11.
[Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer].
Zhonghua Zhong Liu Za Zhi
; 30(6): 469-72, 2008 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-19024526
12.
[The clinical diagnosis and analysis of pulmonary mucosa associated lymphoid tissue lymphoma].
Zhonghua Jie He He Hu Xi Za Zhi
; 30(3): 167-9, 2007 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-17572992
13.
High feasibility of liquid-based cytological samples for detection of EGFR mutations in Chinese patients with NSCLC.
Asian Pac J Cancer Prev
; 15(18): 7885-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25292082
14.
Efficacy of first-line chemotherapy affects the second-line setting response in patients with advanced non-small cell lung cancer.
Asian Pac J Cancer Prev
; 15(16): 6799-804, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25169528
15.
Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with clinical outcome of erlotinib treatment.
Chin Med J (Engl)
; 126(20): 3931-5, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24157160
16.
Erlotinib treatment for persistent spontaneous pneumothorax in non-small cell lung cancer: a case report.
Chin Med J (Engl)
; 123(23): 3501-3, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22166539
Resultados
1 -
16
de 16
1
Próxima >
>>